BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36997008)

  • 1. Cancer stem cell in prostate cancer progression, metastasis and therapy resistance.
    Verma P; Shukla N; Kumari S; Ansari MS; Gautam NK; Patel GK
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188887. PubMed ID: 36997008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy.
    Leão R; Domingos C; Figueiredo A; Hamilton R; Tabori U; Castelo-Branco P
    Urol Int; 2017; 99(2):125-136. PubMed ID: 28142149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into prostate cancer stem cells.
    Chen X; Rycaj K; Liu X; Tang DG
    Cell Cycle; 2013 Feb; 12(4):579-86. PubMed ID: 23370446
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Das B; Pal B; Bhuyan R; Li H; Sarma A; Gayan S; Talukdar J; Sandhya S; Bhuyan S; Gogoi G; Gouw AM; Baishya D; Gotlib JR; Kataki AC; Felsher DW
    Cancer Res; 2019 Aug; 79(16):4015-4025. PubMed ID: 31266772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties.
    Liu J; Ma L; Xu J; Liu C; Zhang J; Liu J; Chen R; Zhou Y
    Int J Oncol; 2013 Feb; 42(2):453-9. PubMed ID: 23229446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer stem cell biology.
    Yu C; Yao Z; Jiang Y; Keller ET
    Minerva Urol Nefrol; 2012 Mar; 64(1):19-33. PubMed ID: 22402315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells.
    Pérez G; López-Moncada F; Indo S; Torres MJ; Castellón EA; Contreras HR
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer cells stemness: A doorstep to targeted therapy.
    Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemosensitization of prostate cancer stem cells in mice by angiogenin and plexin-B2 inhibitors.
    Li S; Goncalves KA; Lyu B; Yuan L; Hu GF
    Commun Biol; 2020 Jan; 3(1):26. PubMed ID: 31942000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Stemness/Epithelial-Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target.
    Castellón EA; Indo S; Contreras HR
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.
    Zhang L; Jiao M; Li L; Wu D; Wu K; Li X; Zhu G; Dang Q; Wang X; Hsieh JT; He D
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):675-86. PubMed ID: 22237455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer.
    Costa CD; Justo AA; Kobayashi PE; Story MM; Palmieri C; Laufer Amorim R; Fonseca-Alves CE
    Int J Biochem Cell Biol; 2019 Mar; 108():21-28. PubMed ID: 30633985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer.
    Guzel E; Karatas OF; Duz MB; Solak M; Ittmann M; Ozen M
    Prostate; 2014 Nov; 74(15):1498-505. PubMed ID: 25175483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype.
    Gorodetska I; Lukiyanchuk V; Peitzsch C; Kozeretska I; Dubrovska A
    Int J Cancer; 2019 Dec; 145(11):2974-2985. PubMed ID: 30968962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges.
    Yun EJ; Lo UG; Hsieh JT
    Asian J Urol; 2016 Oct; 3(4):203-210. PubMed ID: 29264188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular signature of cancer stem cells isolated from prostate carcinoma and expression of stem markers in different Gleason grades and metastasis.
    Castellón EA; Valenzuela R; Lillo J; Castillo V; Contreras HR; Gallegos I; Mercado A; Huidobro C
    Biol Res; 2012; 45(3):297-305. PubMed ID: 23283439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells.
    Püschel J; Dubrovska A; Gorodetska I
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer.
    Castillo V; Valenzuela R; Huidobro C; Contreras HR; Castellon EA
    Int J Oncol; 2014 Sep; 45(3):985-94. PubMed ID: 24990514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.